Braxia Scientific Corp C.BRAX

A Real Honour. 🏆

[newcoin]

TORONTO, April 1, 2022 /CNW/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company with clinics providing innovative ketamine treatments for persons with depression and related disorders, is pleased to announce that CEO, Dr. Roger McIntyre and Chief Medical and Scientific Officer, Dr. Josh Rosenblatt have been invited to present at the Ketamine and Related Compounds 2022 International Conference hosted by University of Oxford in Oxford, England. This meeting is one of the largest International Conferences on ketamine research, development, and clinical implementation.

[cautiousguy]

Never doubted his academic credentials however, Roger is one of thirty 1/2 hour presentations with thirteen of those thirty focused on Ketimine. Rosenblatt is presenting separately in another 1/2 hour session.  Read the program notes instead of trying to "impress" us with what is a cut and paste of a press release you have not fully read/researched/comprehended. 

[newcoin]

This is not about YOU. I know that may be hard to comprehend. This chat board exists to inform investors about BRAXIA and have meaningful discussions about investments in this opportinity. If you want to be a little b1tch do it somewhere else.

[cautiousguy]

The key word being "meaningful."   Factual, contextual, not hyperbolic.  

[TheLove4Money]

This won't do anything for investors.. he's not Elon Musk.. Talk is cheap, you and Roger do a lot of this..